Tociluzimab administation and monitoring in Covid-19
Conclusions: TCZ seems safe. Infections within 3 months approach 30%. Our cohort does not have a control group, and we have not corrected for confounders, but BBV serology must be sent- increased vigilance is required.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Keidan, N., Aujayeb, A., Aujayeb, A. Tags: 10.01 - Respiratory infections and bronchiectasis Source Type: research
More News: Cellulitis | COVID-19 | Liver | Osteomyelitis | Respiratory Medicine | Septicaemia | Urology & Nephrology